JP2781594B2 - 5α-reductase activity inhibitor - Google Patents
5α-reductase activity inhibitorInfo
- Publication number
- JP2781594B2 JP2781594B2 JP1096979A JP9697989A JP2781594B2 JP 2781594 B2 JP2781594 B2 JP 2781594B2 JP 1096979 A JP1096979 A JP 1096979A JP 9697989 A JP9697989 A JP 9697989A JP 2781594 B2 JP2781594 B2 JP 2781594B2
- Authority
- JP
- Japan
- Prior art keywords
- hair
- reductase activity
- activity inhibitor
- extract
- spruce
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 230000000694 effects Effects 0.000 title claims description 41
- 108010066551 Cholestenone 5 alpha-Reductase Proteins 0.000 title claims description 20
- 239000003112 inhibitor Substances 0.000 title claims description 13
- 241000218657 Picea Species 0.000 claims description 17
- 244000183685 Citrus aurantium Species 0.000 claims 1
- 235000007716 Citrus aurantium Nutrition 0.000 claims 1
- 235000000228 Citrus myrtifolia Nutrition 0.000 claims 1
- 235000016646 Citrus taiwanica Nutrition 0.000 claims 1
- 210000004209 hair Anatomy 0.000 description 23
- 238000012360 testing method Methods 0.000 description 14
- 230000003779 hair growth Effects 0.000 description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 230000000052 comparative effect Effects 0.000 description 9
- 238000010998 test method Methods 0.000 description 8
- NVKAWKQGWWIWPM-ABEVXSGRSA-N 17-β-hydroxy-5-α-Androstan-3-one Chemical compound C1C(=O)CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CC[C@H]21 NVKAWKQGWWIWPM-ABEVXSGRSA-N 0.000 description 6
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 6
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 6
- 239000002537 cosmetic Substances 0.000 description 6
- YNBADRVTZLEFNH-UHFFFAOYSA-N methyl nicotinate Chemical compound COC(=O)C1=CC=CN=C1 YNBADRVTZLEFNH-UHFFFAOYSA-N 0.000 description 6
- 210000003491 skin Anatomy 0.000 description 6
- 201000004384 Alopecia Diseases 0.000 description 5
- 230000005764 inhibitory process Effects 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 108090000854 Oxidoreductases Proteins 0.000 description 4
- 102000004316 Oxidoreductases Human genes 0.000 description 4
- 229960003473 androstanolone Drugs 0.000 description 4
- 239000006071 cream Substances 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 208000001840 Dandruff Diseases 0.000 description 3
- 206010040880 Skin irritation Diseases 0.000 description 3
- 239000003098 androgen Substances 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 238000006911 enzymatic reaction Methods 0.000 description 3
- 230000003676 hair loss Effects 0.000 description 3
- 208000024963 hair loss Diseases 0.000 description 3
- 229960001238 methylnicotinate Drugs 0.000 description 3
- 235000001968 nicotinic acid Nutrition 0.000 description 3
- 239000011664 nicotinic acid Substances 0.000 description 3
- 229960003512 nicotinic acid Drugs 0.000 description 3
- 230000003658 preventing hair loss Effects 0.000 description 3
- 210000004761 scalp Anatomy 0.000 description 3
- 230000036556 skin irritation Effects 0.000 description 3
- 231100000475 skin irritation Toxicity 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 229960003604 testosterone Drugs 0.000 description 3
- 235000015961 tonic Nutrition 0.000 description 3
- 230000001256 tonic effect Effects 0.000 description 3
- 235000002566 Capsicum Nutrition 0.000 description 2
- 102000011782 Keratins Human genes 0.000 description 2
- 108010076876 Keratins Proteins 0.000 description 2
- 239000006002 Pepper Substances 0.000 description 2
- 241000722363 Piper Species 0.000 description 2
- 235000016761 Piper aduncum Nutrition 0.000 description 2
- 235000017804 Piper guineense Nutrition 0.000 description 2
- 235000008184 Piper nigrum Nutrition 0.000 description 2
- 206010039792 Seborrhoea Diseases 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 206010068168 androgenetic alopecia Diseases 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 210000003128 head Anatomy 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 229940098465 tincture Drugs 0.000 description 2
- 229960000716 tonics Drugs 0.000 description 2
- MUMGGOZAMZWBJJ-WLRIMQDWSA-N (8r,9s,10r,13s,14s,17s)-10,13-dimethyl-17-oxidanyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=[14CH]1 MUMGGOZAMZWBJJ-WLRIMQDWSA-N 0.000 description 1
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- 238000012935 Averaging Methods 0.000 description 1
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 description 1
- 208000019300 CLIPPERS Diseases 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 239000007995 HEPES buffer Substances 0.000 description 1
- ACFIXJIJDZMPPO-NNYOXOHSSA-N NADPH Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](OP(O)(O)=O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 ACFIXJIJDZMPPO-NNYOXOHSSA-N 0.000 description 1
- 240000004371 Panax ginseng Species 0.000 description 1
- 235000002789 Panax ginseng Nutrition 0.000 description 1
- 208000004403 Prostatic Hyperplasia Diseases 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 208000021930 chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids Diseases 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000002951 depilatory effect Effects 0.000 description 1
- 235000011869 dried fruits Nutrition 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 210000003780 hair follicle Anatomy 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229940116257 pepper extract Drugs 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000004080 punching Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000012925 reference material Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Description
【発明の詳細な説明】 〔産業上の利用分野〕 本発明は、トウヒ抽出エキスからなる5α−リダクタ
ーゼ活性阻害剤に関する。The present invention relates to a 5α-reductase activity inhibitor comprising a spruce extract.
近年、育毛等に関し、ホルモンの関与が示唆されてい
る。つまり、毛乳頭細胞を含めた毛包において、男性ホ
ルモン(テストステロン)は、5α−リダクターゼ(Δ
4−3−ケトステロイド−5α−オキシドリダクター
ゼ)により、活性型男性ホルモン(ジヒドロテストステ
ロン)に活性化され、さらに受容体と結合し、核に取り
込まれ、DNAレベルで情報を伝達する。伝達された情報
により、ケラチン合成に関連する酸素合成が制御され、
毛髪のケラチン合成を抑制し、最終的に脱毛を促進させ
る。したがって、養毛剤開発にあたり、男性ホルモン活
性化酵素である5α−リダクターゼの活性阻害物質に関
する研究が注目されている。また、前立腺肥大症の予防
・治療薬としても、5α−リダクターゼ活性阻害剤が注
目されている。In recent years, the involvement of hormones in hair growth and the like has been suggested. That is, in the hair follicle including the hair papilla cells, the male hormone (testosterone) is replaced by 5α-reductase (Δ
4-3-Ketosteroid-5α-oxide reductase) activates the active androgen (dihydrotestosterone), binds to a receptor, is taken up into the nucleus, and transmits information at the DNA level. The transmitted information regulates oxygen synthesis related to keratin synthesis,
Suppresses keratin synthesis in hair and eventually promotes hair loss. Therefore, in the development of a hair restorer, attention has been paid to studies on inhibitors of the activity of 5α-reductase, which is an androgen activating enzyme. In addition, 5α-reductase activity inhibitors have received attention as preventive and therapeutic agents for benign prostatic hyperplasia.
従来より養毛化粧料等に配合されているトウガラシチ
ンキ,センブリエキス,朝鮮ニンジンエキス,ニコチン
酸,ニコチン酸メチル等の頭皮の血行促進物質は、5α
−リダクターゼ活性阻害能は殆どなく、5α−リダクタ
ーゼ活性阻害剤としての効果はないのである。Conventionally, scalp blood circulation promoting substances such as pepper tincture, assembly extract, Korean ginseng extract, nicotinic acid, methyl nicotinate, etc., which are blended in hair nourishing cosmetics and the like, are 5α.
-Has little ability to inhibit reductase activity, and has no effect as a 5α-reductase activity inhibitor.
本発明は、例えば、育毛,脱毛予防及びふけ防止等の
諸効果を改善するために養毛化粧料等に配合可能な5α
−リダクターゼ活性阻害剤を提供することを目的として
いる。The present invention relates to a 5α compound that can be added to a hair restoration cosmetic or the like to improve various effects such as hair growth, hair loss prevention and dandruff prevention.
-To provide a reductase activity inhibitor.
本発明は、トウヒ抽出エキスからなる5α−リダクタ
ーゼ活性阻害剤である。The present invention is a 5α-reductase activity inhibitor comprising a spruce extract.
本発明に用いるトウヒは、ダイダイ(Citrus auranti
um Linn.subsp.amara Engler)の成熟した果実の皮を乾
燥したものである。The spruce used in the present invention is a die-dai (Citrus auranti).
um Linn.subsp.amara Engler) is a dried fruit peel.
本発明に用いるトウヒ抽出エキスは、下記の方法にて
得られる。The spruce extract used in the present invention is obtained by the following method.
トウヒの果実比を好ましくは乾燥、粉砕した後、溶剤
中で浸漬抽出するか、あるいはソックスレー抽出器等の
抽出器を用いて抽出することにより得られる。なお、抽
出溶剤としては、メタノールやエタノール等の有機溶媒
や水が挙げられるが、中でも含水アルコールが好まし
い。The spruce fruit ratio is preferably obtained by drying and pulverizing, followed by immersion extraction in a solvent or extraction using an extractor such as a Soxhlet extractor. In addition, as the extraction solvent, an organic solvent such as methanol and ethanol and water can be mentioned, and among them, a hydroalcohol is preferable.
本発明のトウヒ抽出エキスは、適度な経皮吸収性を有
する為、頭皮内における該薬物の有効濃度を持続するも
のであって、皮膚刺激性も低く、5α−リダクターゼ活
性阻害能を有するものである。例えば、この5α−リダ
クターゼ活性阻害能が、毛乳頭細胞における活性型男性
ホルモン(ジヒドロテストステロン)産生を抑制するこ
とにより、育毛,脱毛予防効果を発現し、更には、頭皮
代謝機能を正常化して、ふけ防止効果を高める養毛化粧
料等に応用が可能である。The spruce extract of the present invention has an appropriate transdermal absorption property, so that the effective concentration of the drug in the scalp is maintained, the skin irritation is low, and the activity of inhibiting 5α-reductase activity is low. is there. For example, the ability to inhibit 5α-reductase activity suppresses the production of active androgen (dihydrotestosterone) in hair papilla cells, thereby exhibiting hair growth and hair loss prevention effects, and further normalizes the scalp metabolic function. It can be applied to hair-growing cosmetics and the like that enhance the effect of preventing dandruff.
トウヒ抽出エキスからなる5α−リダクターゼ活性阻
害剤の配合量は、例えば、養毛化粧料の場合には、組成
物の全重量に対して乾燥純分として0.004〜0.4重量%
(以下wt%と略記する。)であればよく、好ましくは0.
004〜3.2wt%である。配合量が0.004wt%未満では、本
発明の目的とする効果に充分でなく、一方0.4wt%を超
えても、その増加分に見合った効果の向上は望めないも
のである。The amount of the 5α-reductase activity inhibitor consisting of a spruce extract is, for example, in the case of a hair nourishing cosmetic, 0.004 to 0.4% by weight as a dry matter based on the total weight of the composition.
(Hereinafter abbreviated as wt%), and is preferably 0.
004 to 3.2 wt%. If the amount is less than 0.004% by weight, the desired effect of the present invention is not sufficient. If the amount exceeds 0.4% by weight, the effect corresponding to the increase cannot be expected.
以下、実施例及び比較例に基づいて本発明を詳細す
る。Hereinafter, the present invention will be described in detail based on Examples and Comparative Examples.
尚、実施例に記載の5α−リダクターゼ活性阻害試験
法,マウス毛成長促進効果試験法,ヒト頭髪毛成長促進
効果試験法及び実用試験法を下記に示す。The 5α-reductase activity inhibition test method, mouse hair growth promotion effect test method, human hair growth promotion effect test method and practical test methods described in the Examples are shown below.
(1)5α−リダクターゼ活性阻害試験法 重量350〜400gの雄性ラットより摘出した前立腺(湿
重量、約4g)に3倍量の0.25Mシュークロースを含む0.1
M HEPES(pH7.4)を加え、テフロン製ポッター型ホモ
ジナイザーを用いてホモジネートした。次いで3,000rpm
で10分間遠心し、沈渣を10mlの上記緩衝溶液に懸濁し、
再び3,000rpmで10分間遠心した。この沈渣に3mlの上記
緩衝溶液を加えて再び懸濁し、これを酵素溶液として使
用した。(1) 5α-Reductase activity inhibition test method Prostate (wet weight, about 4 g) isolated from a male rat weighing 350 to 400 g contains 3 times the amount of 0.15 M sucrose containing 0.15 M sucrose.
M HEPES (pH 7.4) was added, and homogenized using a Teflon potter homogenizer. Then 3,000rpm
Centrifuge for 10 minutes, suspend the precipitate in 10 ml of the above buffer solution,
Centrifugation was again performed at 3,000 rpm for 10 minutes. The precipitate was resuspended by adding 3 ml of the above buffer solution, and used as an enzyme solution.
酵素活性は、〔4−14C〕−テストステロン(1.5nmo
l,1.5×105cpm),NADPH(0.5μmol),上記酵素溶液
(0.03ml)及び各試料を含む全容0.1mlの反応溶液を37
℃で60分間インキュベートした(酵素反応は基質の〔4
−14C〕−テストステロンを添加することにより開始し
た)。酵素反応はクロロホルム/メタノール(1:2)の
混合溶媒0.4mlを混和して停止し、その後3,000rpmで10
分間遠心分離した。上清の0.05mlをシリカゲルガラスプ
レートに吸着させ、展開溶媒としてクロロホルム/メタ
ノール/酢酸(99.2/0.6/0.2)を用いて室温で15cm展開
した。標準物質としてテストステロン及びジヒドロテス
トステロン(DHT)を同時に展開した。展開終了後薄層
プレートをクロマトスキャナーを用いて走査し、酵素反
応により生じたジヒドロテストステロン(DHT)の生成
量を測定し、5α−リダクターゼ活性阻害率(%)を算
出した。Enzyme activity, [4-14 C] - testosterone (1.5Nmo
l, 1.5 × 10 5 cpm), NADPH (0.5 μmol), the above enzyme solution (0.03 ml) and a reaction solution having a total volume of 0.1 ml containing each sample.
C. for 60 minutes (enzyme reaction was [4
- 14 C] - it was initiated by the addition of testosterone). The enzymatic reaction was stopped by mixing 0.4 ml of a mixed solvent of chloroform / methanol (1: 2), and then stopped at 3,000 rpm for 10 minutes.
Centrifuged for minutes. 0.05 ml of the supernatant was adsorbed on a silica gel glass plate, and developed using chloroform / methanol / acetic acid (99.2 / 0.6 / 0.2) as a developing solvent for 15 cm at room temperature. Testosterone and dihydrotestosterone (DHT) were simultaneously developed as reference materials. After the development was completed, the thin plate was scanned using a chromatoscanner, the amount of dihydrotestosterone (DHT) produced by the enzyme reaction was measured, and the 5α-reductase activity inhibition rate (%) was calculated.
阻害率(%)=〔1−(A/B)〕×100 A:各試料を添加した場合のDHTの生成量 B:無添加の場合のDHTの生成量 (2)マウス毛成長促進効果試験法 ddY系白色マウス(雄、6週齢、平均重量35g)の尾部
よりの背部皮膚を電気バリカンで刈ったあと、脱毛クリ
ームにより完全脱毛し、翌日より実施例及び比較例の各
試料を被験部皮膚に毎日1回、一匹当り0.2ml塗布し
た。一試料に対して動物一群10匹使用した。Inhibition rate (%) = [1- (A / B)] × 100 A: Amount of DHT produced when each sample was added B: Amount of DHT produced without addition (2) Mouse hair growth promoting effect test Method The skin of the back of the tail of a ddY strain white mouse (male, 6 weeks old, average weight 35 g) was cut with an electric hair clipper, and then completely depilated with a depilatory cream. From the next day, each sample of Examples and Comparative Examples was tested. 0.2 ml per animal was applied to the skin once a day. A group of 10 animals was used for one sample.
養毛効果の判定は、下表に示す判定基準による肉眼評
定の評価点と、毛長,毛重量を対照群と比較することに
より行った。The hair growth effect was determined by comparing the evaluation points of the visual evaluation according to the criteria shown in the table below, and the hair length and hair weight with the control group.
実験開始後14日目に動物を屠殺し判定基準により肉眼
評定し、その評価点を合計し、一匹当りの平均評価を求
めた。さらに、被験部の皮膚を除去し、直径12mmのパン
チで一定面積の皮膚を打ち抜き乾燥した後、毛の重量を
測定し、その中の20本の毛の長さについても測定し、各
々の平均値を算出した。On the 14th day after the start of the experiment, the animals were sacrificed, visually evaluated according to criteria, and their evaluation points were totaled to obtain an average evaluation per animal. Furthermore, after removing the skin of the test part, punching out a certain area of skin with a punch having a diameter of 12 mm and drying, the weight of the hair was measured, and the length of the 20 hairs in the hair was also measured. Values were calculated.
(3)ヒト頭髪毛成長促進効果試験法 男性型脱毛症患者である被試験者10名の頭部の耳の上
5cmの位置の頭髪を左右5cmの位置の頭髪を左右2ヶ所に
於て直径1cmの円形状に剃毛した被験部位に、実施例ま
たは比較例の試料を左側に毎日朝夕2回、約3ml塗布
し、無処理の右側と比較した。結果の測定は、試験開始
後28日目に、左右の被験部位の毛髪各々20本ずつを剃毛
し、左側(実施例または比較例を塗布)の毛20本の長さ
の平均値(B)を右側(無処置)の毛20本の長さの平均
値(A)で除した値を求めて評価した。 (3) Human hair growth promotion effect test method On the ears of the heads of 10 test subjects who are male pattern baldness patients
A sample of the example or the comparative example was applied to the test site where the hair at a position of 5 cm was shaved in a circular shape having a diameter of 1 cm at two places on the left and right at the left and right sides of the hair at a position of 5 cm. And compared to the untreated right side. The results were measured on the 28th day after the start of the test by shaving 20 hairs on each of the left and right test sites, and averaging the length of the 20 hairs on the left side (to which the example or the comparative example was applied) (B ) Was divided by the average value (A) of the lengths of the 20 right hairs (untreated) to evaluate.
判定結果は、被試験者10名の(B)/(A)の平均値
で示した。The judgment results were shown as the average of (B) / (A) of 10 test subjects.
(4)実用試験法 男性型脱毛症患者である被試験者20名の頭部に毎日朝
夕2回、連続6ヶ月間塗布した後の効果を評価した。試
験結果は、育毛効果,脱毛予防効果,ふけ防止効果の各
項に対して、「生毛が剛毛化した或は生毛が増加し
た」,「脱毛が少なくなった」,「ふけが少なくなっ
た」と回答した人数で示した。(4) Practical test method The effect of application to the heads of 20 test subjects who are male pattern baldness patients twice daily in the morning and evening for 6 consecutive months was evaluated. The test results show that the hair growth effect, the hair loss prevention effect, and the dandruff prevention effect are “hair is bristle or hair is increased”, “hair loss is reduced”, and “hair loss is reduced”. The number of respondents. "
なお、実施例中のトウヒ抽出エキスは、下記の方法に
よって得たものを用いた。In addition, the spruce extract extracted in the Example used what was obtained by the following method.
トウヒの果実皮を乾燥、粉砕したもの30.0gを含水エ
タノール200ml(エタノール90.0wt%)を用い還流抽出
し、抽出エキスを減圧下濃縮してトウヒ抽出エキス100m
lを得た。このうち、トウヒ抽出エキス乾燥純分は4wt%
であった。The spruce fruit peel was dried and pulverized, and 30.0 g of the spruce extract was subjected to reflux extraction using 200 ml of aqueous ethanol (90.0 wt% of ethanol).
got l. 4wt% of dry spruce extract extract
Met.
実施例1〜4、比較例1〜4 オイリーヘアートニック 下記の原料組成に於て、第1表に記載のごとく、各種
成分(5α−リダクターゼ活性阻害剤)を配合して各々
のヘアートニックを調製し、前記の諸試験を実施した。Examples 1-4, Comparative Examples 1-4 Oily hair tonics In the following raw material composition, as shown in Table 1, various components (5α-reductase activity inhibitor) were blended to prepare respective hair tonics. Then, the various tests described above were performed.
(1)組成 (2)調製法 (B)成分中、ニコチン酸,ニコチン酸メチルは
(A)成分に、トウガラシチンキ,トウヒ抽出エキスは
(C)成分に溶解し、(A),(B)成分を各々均一に
溶解した後、(A)成分と(B)成分を混合撹拌分散
し、次いで容器に充填する。使用時には内容物を均一に
振盪分散して使用する。(1) Composition (2) Preparation method In the component (B), nicotinic acid and methyl nicotinate are dissolved in the component (A), and pepper extract and spruce extract are dissolved in the component (C). , And the components (A) and (B) are mixed, stirred and dispersed, and then charged into a container. When used, the contents are shaken and dispersed uniformly.
(3)特性 各オイリーヘアートニックの諸試験を実施した結果を
第1表に記載した。(3) Characteristics Table 1 shows the results of various tests performed on each oily hair tonic.
第1表に示すごとく、比較例1〜4は殆ど5α−リダ
クターゼ活性阻害能を有しなかった。また、比較例2,3,
4は皮膚刺激があり、ヒト皮膚での試験は不可能であっ
た。As shown in Table 1, Comparative Examples 1 to 4 hardly had the ability to inhibit 5α-reductase activity. In addition, Comparative Examples 2, 3,
4 had skin irritation, and testing on human skin was not possible.
実施例1〜4の本発明のトウヒ抽出エキスからなる5
α−リダクターゼ活性阻害剤は優れた5α−リダクター
ゼ活性阻害能を有するとともに、諸試験の総てに亘って
明らかに良好な結果を示した。5 consisting of the spruce extract of the present invention of Examples 1-4
The α-reductase activity inhibitor has an excellent ability to inhibit 5α-reductase activity, and showed clearly good results in all tests.
尚、実施例1〜4はヒト皮膚での諸試験に於て皮膚刺
激は生じなかった。In Examples 1-4, no skin irritation occurred in various tests on human skin.
実施例5〜8、比較例5〜8 ヘアークリーム 実施例1と同様にして各々のヘアークリームを調製し
て諸試験を実施し、その結果を第1表に記載した。Examples 5 to 8 and Comparative Examples 5 to 8 Hair Creams Each hair cream was prepared and tested in the same manner as in Example 1, and the results are shown in Table 1.
(1)組成 (2)調製法 (B)成分中、ニコチン酸,ニコチン酸メチルは
(A)成分に、トウガラシチンキ,トウヒ抽出エキスは
(C)成分に溶解し、(A),(C)成分の各々温度80
℃に加熱溶解したものを混合した。次いで撹拌しつつ冷
却して温度50℃になったところで(D)成分を加え、更
に温度30℃まで撹拌を続けて各ヘアー クリームを調製した。(1) Composition (2) Preparation method In the component (B), nicotinic acid and methyl nicotinate are dissolved in the component (A), and the pepper tincture and spruce extract are dissolved in the component (C), and each of the components (A) and (C) has a temperature. 80
What was heated and melted at ° C was mixed. Then, while stirring and cooling to a temperature of 50 ° C., add the component (D) and continue stirring to a temperature of 30 ° C. A cream was prepared.
(3)特性 第1表に示すごとく、本発明の5α−リダクターゼ活
性阻害剤であるトウヒ抽出エキスを配合した実施例5〜
8の養毛化粧料は、比較例5〜8と比較して高い5α−
リダクターゼ活性阻害率を示すとともに、諸試験に於て
優れた効果を示した。(3) Properties As shown in Table 1, Examples 5 to 5 containing a spruce extract which is a 5α-reductase activity inhibitor of the present invention were blended.
The hair growth cosmetic composition No. 8 has a higher 5α- in comparison with Comparative Examples 5 to 8.
In addition to showing the reductase activity inhibition rate, it showed an excellent effect in various tests.
以上記載のごとく、トウヒ抽出エキスからなる本発明
の5α−リダクターゼ活性阻害剤は、優れた5α−リダ
クターゼ活性の阻害能を有し、養毛化粧料剤等に応用が
可能である。As described above, the 5α-reductase activity inhibitor of the present invention comprising a spruce extract has an excellent ability to inhibit 5α-reductase activity, and can be applied to hair growth cosmetics and the like.
Claims (1)
ara Engler)の抽出エキスからなる5α−リダクターゼ
活性阻害剤。(1) Spruce (Citrus aurantium Linn.subsp.am)
5α-reductase activity inhibitor comprising an extract of ara Engler).
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1096979A JP2781594B2 (en) | 1989-04-17 | 1989-04-17 | 5α-reductase activity inhibitor |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1096979A JP2781594B2 (en) | 1989-04-17 | 1989-04-17 | 5α-reductase activity inhibitor |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH02275815A JPH02275815A (en) | 1990-11-09 |
JP2781594B2 true JP2781594B2 (en) | 1998-07-30 |
Family
ID=14179333
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP1096979A Expired - Lifetime JP2781594B2 (en) | 1989-04-17 | 1989-04-17 | 5α-reductase activity inhibitor |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2781594B2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH10265349A (en) * | 1997-03-26 | 1998-10-06 | Shiseido Co Ltd | Hair tonic |
JPH10265350A (en) * | 1997-03-26 | 1998-10-06 | Shiseido Co Ltd | Hair tonic |
JP2009249361A (en) * | 2008-04-09 | 2009-10-29 | Tomoatsu Tokutomi | Hair or scalp composition |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61291508A (en) * | 1985-06-19 | 1986-12-22 | Yutaka Miyauchi | Beauty lotion |
-
1989
- 1989-04-17 JP JP1096979A patent/JP2781594B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JPH02275815A (en) | 1990-11-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Roy et al. | Development and evaluation of polyherbal formulation for hair growth–promoting activity | |
CN110200838A (en) | A kind of complex polypeptide nano vesicle and its preparation method and application | |
JP2000229834A (en) | Cosmetic | |
JP3223404B2 (en) | Hair restorer | |
WO2001074326A1 (en) | Agents improving skin barrier function | |
JPH11240823A (en) | Activator for hair papilla | |
JP2002536313A (en) | Cholesterol sulfate composition for enhancing stratum corneum function | |
JP2977648B2 (en) | Hair restoration cosmetics | |
JP2781594B2 (en) | 5α-reductase activity inhibitor | |
Wolff | Diseases of hair | |
JP4215906B2 (en) | Cosmetics | |
JP4162823B2 (en) | Hair cosmetics | |
JPH05286835A (en) | Hair-raising cosmetic | |
WO2005076757A2 (en) | Hair and eyebrow, eyelashes growth stimulater | |
JP3162962B2 (en) | Hair restoration | |
JPH02218604A (en) | Hair-tonic cosmetic | |
JPH0412243B2 (en) | ||
JP2000026269A (en) | Cosmetic | |
JP2994993B2 (en) | Hair restoration cosmetics | |
AU2021107428A4 (en) | Herbal hair oil formulation for andorgenetic alopecia: a novel process to produce a novel and effective herbal oil | |
JPH02221215A (en) | Hair tonic cosmetic | |
JPH06183932A (en) | Hair tonic cosmetic | |
JP2000128741A (en) | Hair papilla activator | |
JP2955055B2 (en) | Hair restoration cosmetics | |
JP2758495B2 (en) | Hair restoration cosmetics |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
R371 | Transfer withdrawn |
Free format text: JAPANESE INTERMEDIATE CODE: R371 |
|
S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080515 Year of fee payment: 10 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090515 Year of fee payment: 11 |
|
EXPY | Cancellation because of completion of term |